Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
Oct 1, 2026, 4:10 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 26.03 million as of October 1, 2026. Its market cap has decreased by -62.05% in one year.
Market Cap
26.03M
Enterprise Value
19.52M
Revenue
13.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 26.03M, a decrease of -74.32%. That is a compound annual growth rate of -24.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 26.03M | -70.63% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immutep | 50.11M |
| Botanix Pharmaceuticals | 49.26M |
| Nexsen | 28.03M |
| Neurotech International | 24.24M |
| NeuroScientific Biopharmaceuticals | 23.38M |
| Patrys | 22.27M |
| Imugene | 21.06M |
| Proteomics International Laboratories | 20.67M |